Clinical Trial: A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL




Official Title: A Phase 1/2, Open-Label Clinical Study to Evaluate Safety, Tolerability, and Efficacy of NGN-401 in Pediatric Subjects With Rett Syndrome

Brief Summary: This study will evaluate the safety profile of the investigational gene therapy, NGN-401, in female children with typical Rett syndrome.